Chatham Lodging Trust (CLDT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Entered contracts to sell five older, low-RevPAR hotels for $80 million, with proceeds to pay down debt and reinvest in higher-growth assets.
Q3 2024 revenue was $87.2 million, up 0.5% year-over-year, driven by a 1.3% increase in same property RevPAR and the acquisition of a Phoenix hotel, offset by the sale of a Denver property.
Net income for Q3 2024 was $4.3 million, down from $7.5 million in Q3 2023, primarily due to higher interest expense and operating costs.
EBITDA and FFO near the top of guidance, driven by RevPAR growth and controlled expenses.
Strong liquidity and lowest leverage in over a decade, with only $30 million of debt maturing in the next year.
Financial highlights
Q3 2024 hotel EBITDA was $32.2 million; adjusted EBITDA $29.6 million; adjusted FFO $0.35 per share.
Q3 2024 revenue was $87.2 million, with same property RevPAR up 1.3% to $150; ADR rose 1.3% to $188; occupancy flat at 80%.
Net income to common shareholders was $2.3 million for Q3 2024, down from $5.3 million in Q3 2023.
GOP margin at 44.5% and hotel EBITDA margin at 37.1% in Q3.
Cash, cash equivalents, and restricted cash totaled $28.8 million at September 30, 2024, down $56.9 million from year-end 2023.
Outlook and guidance
Q4 2024 guidance: RevPAR growth of 1%-3%, adjusted EBITDA of $19-$21 million, adjusted FFO per share of $0.15-$0.18.
Full-year 2024 RevPAR expected to exceed 2019 levels for the first time since the pandemic.
Management expects modest RevPAR growth for the remainder of 2024, with continued recovery in business travel and inflationary pressures on costs.
Benefit costs expected to be flat year-over-year in 2025.
Guidance assumes three hotel renovations, $14 million mortgage repayment, and no additional acquisitions or equity/debt issuance.
Latest events from Chatham Lodging Trust
- Industry-leading margins and RevPAR, strong balance sheet, and upside from tech market recovery.CLDT
Investor presentation2 Mar 2026 - Industry-leading margins, reduced leverage, and a return to profitability set the stage for 2026.CLDT
Q4 202527 Feb 2026 - Q2 RevPAR up 4%, Phoenix hotel acquired, and balance sheet strengthened despite higher costs.CLDT
Q2 20242 Feb 2026 - Q4 RevPAR up 4%, margins expand, and leverage falls as tech markets drive growth.CLDT
Q4 202423 Dec 2025 - Proxy covers trustee elections, auditor ratification, executive pay, and equity plan amendment.CLDT
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, compensation, and plan amendment.CLDT
Proxy Filing2 Dec 2025 - Board urges approval of Equity Incentive Plan amendment to sustain aligned, cost-effective pay.CLDT
Proxy Filing2 Dec 2025 - Outperforming peers in RevPAR and margins, with strong growth potential from business travel recovery.CLDT
Investor Presentation27 Nov 2025 - Q2 2025 delivered resilient RevPAR, reduced leverage, and robust share repurchases.CLDT
Q2 202523 Nov 2025